Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pratima Dibba

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Diseases (Basel, Switzerland)|May 23, 2018
Case Report of Isoniazid-Related Acute Liver Failure Requiring Liver TransplantationAndrew A Li, Pratima Dibba, George Cholankeril, et al.
Nutrition and Metabolic Insights|July 17, 2019
Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A CommentaryPratima Dibba, Andrew A Li, George Cholankeril, et al.
Surgical Endoscopy|June 26, 2020
Bevacizumab does not increase risk of perforation in patients undergoing percutaneous endoscopic gastrostomy or jejunostomy placementPratima Dibba, Emmy Ludwig, Delia Calo, et al.
Medicines (Basel, Switzerland)|May 31, 2018
Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver DiseasePratima Dibba, Andrew Li, George Cholankeril, et al.
Medicines (Basel, Switzerland)|June 13, 2018
The Role of Cannabinoids in the Setting of CirrhosisPratima Dibba, Andrew A Li, George Cholankeril, et al.
Diseases (Basel, Switzerland)|April 28, 2018
Hepatitis C in PregnancyPratima Dibba, Rosann Cholankeril, Andrew A Li, et al.
Journal of Viral Hepatitis|August 17, 2018
Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016Andrew A Li, Donghee Kim, Won Kim, et al.
Diseases (Basel, Switzerland)|September 22, 2018
Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLDPratima Dibba, Andrew A Li, Brandon J Perumpail, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Diseases (Basel, Switzerland)|May 23, 2018
Case Report of Isoniazid-Related Acute Liver Failure Requiring Liver TransplantationAndrew A Li, Pratima Dibba, George Cholankeril, et al.
Nutrition and Metabolic Insights|July 17, 2019
Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A CommentaryPratima Dibba, Andrew A Li, George Cholankeril, et al.
Surgical Endoscopy|June 26, 2020
Bevacizumab does not increase risk of perforation in patients undergoing percutaneous endoscopic gastrostomy or jejunostomy placementPratima Dibba, Emmy Ludwig, Delia Calo, et al.
Medicines (Basel, Switzerland)|May 31, 2018
Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver DiseasePratima Dibba, Andrew Li, George Cholankeril, et al.
Medicines (Basel, Switzerland)|June 13, 2018
The Role of Cannabinoids in the Setting of CirrhosisPratima Dibba, Andrew A Li, George Cholankeril, et al.
Diseases (Basel, Switzerland)|April 28, 2018
Hepatitis C in PregnancyPratima Dibba, Rosann Cholankeril, Andrew A Li, et al.
Journal of Viral Hepatitis|August 17, 2018
Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016Andrew A Li, Donghee Kim, Won Kim, et al.
Diseases (Basel, Switzerland)|September 22, 2018
Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLDPratima Dibba, Andrew A Li, Brandon J Perumpail, et al.
Pageof 1